The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
9 METERS BIOPHARMA INC | COM | 654405109 | 1,948 | 3,250,000 | SH | SOLE | 3,250,000 | 0 | 0 | ||
AADI BIOSCIENCE INC | COM | 00032Q104 | 2,546 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,155 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 1,579 | 686,599 | SH | SOLE | 686,599 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 10,417 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 12,703 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 7,403 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 16,430 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 3,911 | 94,500 | SH | SOLE | 94,500 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,209 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 4,388 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 5,691 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 10,218 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 12,733 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 1,866 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 6,071 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 3,230 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 7,574 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 7,607 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 6,648 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 405 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 1,739 | 993,714 | SH | SOLE | 993,714 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 10,576 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 1,644 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
PARDES BIOSCIENCES INC | COM | 69945Q105 | 614 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 303 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 5,498 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 2,699 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 3,172 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 3,906 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 1,800 | 473,562 | SH | SOLE | 473,562 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 10,416 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 225,820 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
SPDR SER TR | S&P BIOTECH | 78464A870 | 26,964 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,911 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 2,018 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 7,245 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,743 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 8,624 | 466,403 | SH | SOLE | 466,403 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 1,631 | 1,315,154 | SH | SOLE | 1,315,154 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,057 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 3,691 | 80,000 | SH | SOLE | 80,000 | 0 | 0 |